The 2nd Thailand Hub of Talents in Cancer Immunotherapy International Conference
Cancer Immunotherapy: From Promise to Precision – Delivering Personalized Treatments

Topics (click to watch the video)

• Introduction to the Thailand Hub of Talents in Cancer Immunotherapy
  Prof. Nattiya Hirankarn, MD, PhD
  Director, Cancer Immunotherapy Excellence Center, Chulalongkorn University, Bangkok, Thailand

• Roles of systemic immunity in tumor metastasis and effective immunotherapy
  Assist. Prof. Nathan Reticker-Flynn, PhD
  Department of Otolaryngology-Head & Neck Surgery, Stanford University, Stanford, CA, USA

• Advances and challenges in cancer immunotherapy: Clinician perspective
  Assist. Prof. Jomjit Chantharasamee, MD
  Division of Oncology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

• Off-the-shelf peptide vaccine: Potential use of driver gene mutations
  Assoc. Prof. Aussara Panya, MD, PhD 
  Department of Biology, Faculty of Science, Chiang Mai University, Chiang Mai, Thailand

• Neoantigens: promising targets for osteosarcoma treatment
  Dr. Parunya Chaiyawat, PhD
  Center of Multidisciplinary Technology for Advanced Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

• Potential use of metabolomic characterization of cell and cell constructs
  Assist. Prof. Jutarop Phetcharaburanin, PhD
  Department of Systems Biosciences and Computational Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand

• Efficiency enhancement of NK cell-based immunotherapy with a tri-specific killer engager targeted CD47 for lung cancer
  Dr. Chutipa Chiawpanit, PhD
  Department of Biology, Faculty of Science, Chiang Mai University, Chiang Mai, Thailand

• The advantages of bidirectional promoter-driven dual chimeric antigen receptor (CAR) construct
  Dr. Asmita Khaniya, PhD
  Medical Microbiology Interdisciplinary Program, Graduate School, Chulalongkorn University, Bangkok, Thailand

• Therapeutic potential of fourth-generation CAR-T cells targeting Trop2 for breast cancer treatment
  Dr. Chalermchai Somboonpatarakun, PhD
  Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE-CIT), Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

• Improving efficiency of cisplatin through CRISPR technology in cholangiocarcinoma
  Mr. Natthawut Pratumwan
  Department of Systems Biosciences and Computational Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand

The 2nd Thailand Hub of Talents in Cancer Immunotherapy International Conference
Cancer Immunotherapy: From Promise to Precision – Delivering Personalized Treatments

• Program & Abstracts